Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-08-10

FDA Approved: FLUOXETINE — Supplemental Application (Torrent Pharmaceuticals Limited)

View source ↗

Summary

FDA approved a supplemental application for fluoxetine from Torrent Pharmaceuticals Limited, enabling the generic antidepressant to be manufactured and marketed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluoxetine (Fluoxetine)

Snippet

SUPPL AP for FLUOXETINE (FLUOXETINE)